24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk.

Toshitsugu SugimotoMasataka ShirakiMasao FukunagaHiroshi HaginoTeruki SoneTetsuo NakanoHideaki KishimotoMasako ItoHideki YoshikawaMitsukazu KishidaChika IrieToshitaka Nakamura

Published in: Advances in therapy (2017)

JapicCTI-132276.

Keyphrases

bone mineral density
open label
postmenopausal women
phase iii
phase ii
body composition
study protocol
clinical trial
phase ii study
randomized controlled trial
squamous cell carcinoma
rectal cancer